Why the Prospa and G8 Education share prices both collapsed recently

We examine the earnings downgrades that contributed to the recent investor sell-off of G8 Education and Prospa stock.

Market musings

Yesterday we discussed how amongst all things: the market loves an earnings upgrade.

As we wrote, it was unsurprising that Appen's share price jumped as much as 14% after the company bumped up its full-year EBITDA guidance: from a shy $85m - $90m to $96m - $99m.

Of course, if the market loves an earnings upgrade, the other near-certainty is that the market absolutely hates an earnings downgrade.

Unsurprisingly then, when fresh-faced Prospa (ASX: PGL) and G8 Education (ASX: GEM) both announced earnings downgrades in the last week – the market was not shy about beating their share prices lower.

Below, we take a look at the details of both downgrades.

Practise trading Australian stocks with an IG demo account now

G8 share price: when assumptions fall away

In August the company remained mostly upbeat, noting the following:

'Balancing the performance of the organic centres with our caution in relation to the market environment, the forecast underlying EBIT range for CY19 is $140m - $145m.'

Had the company achieved such goals – or maybe more relevantly kept that estimate stable – it would have marked a slight increase on the company’s 2018 underlying EBIT of $136.3m. Not a big leap, but at the very least not a decline.

The above guidance however, as the company would later announce, was 'predicated upon occupancy growth of mid 1% pts and wage efficiencies.’

It looks as if G8 hasn’t quite hit those targets, with the company last week announcing that 'full-year underlying EBIT forecast is now expected to be $131-$134m for the year.’

Investors responded sharply and swiftly, with the G8 Education share price falling 24% since revealing this earnings downgrade to the market.

The G8 Education (ASX: GEM) share price currently trades at the $1.94 mark – well below its February high of $3.63 per share.

Prospa share price: earnings not so prosperous

Prospa Group Limited (ASX: PGL) listed on the ASX on June 11. The prospectus forecast 1H 2020 originations of $297.4m; revenues of $88.0m and EBITDA (pro forma) of $11.3m.

Good numbers, the market rated, as the Prospa share price ran as high as $5.090. Then, the music stopped. Or maybe more accurately: slowed.

Prospa yesterday revealed to the market that while 1H 2020 originations were actually set to come in a little higher than previously flagged: now at $298.2m; revenue and earnings both were expected to now come in significantly lower. Specifically, 1H 2020 revenue was now expected to come in at around $75.0m, while earnings (EBITDA) was expected even lower at just $4.0m.

The market punished this downgrade accordingly, bidding the stock down as much as 28.57% in the aftermath. PGL currently trades at $2.775 per share.

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

Please see important Research Disclaimer.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access

Live prices on most popular markets

  • Forex
  • Shares
  • Indices
liveprices.javascriptrequired
liveprices.javascriptrequired

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

liveprices.javascriptrequired

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Monday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.